What Causes Gallbladder Cancer: Risks and Conditions

Gallbladder cancer develops through a combination of chronic irritation, metabolic dysfunction, infection, and sometimes inherited anatomy that keeps the gallbladder inflamed for years or decades. The single most common thread is gallstones: the vast majority of gallbladder cancer patients have them, and larger stones carry a higher risk. But gallstones alone are far too common to explain who actually gets this cancer, which remains rare even in populations where stones are widespread. The real picture involves layers of risk factors, some modifiable and some not, that together push gallbladder tissue toward malignancy.

Gallstones and the Role of Chronic Inflammation

Gallstones sit at the center of gallbladder cancer risk. Somewhere between 75 and 90 percent of gallbladder cancer patients have gallstones at the time of diagnosis. The working explanation is straightforward: stones physically irritate the gallbladder wall, triggering repeated cycles of inflammation, tissue repair, and cell turnover. Over many years, that constant cellular damage raises the odds that a mutation sticks.

Stone size matters more than stone count. Evidence consistently shows that stones larger than 3 cm carry the greatest cancer risk, particularly in people who have symptoms from their gallstones like pain or inflammation episodes.¹ Smaller stones still contribute, but the jump in risk with large stones is pronounced enough that some researchers have argued for preventive gallbladder removal in those patients. Gallstones are extremely common worldwide, though. Only a small fraction of people with stones ever develop cancer, which means gallstones are better understood as a necessary background condition for most cases rather than a sole cause.

Who Gets Gallbladder Cancer and Where

Gallbladder cancer has one of the most uneven geographic distributions of any malignancy. Chile historically records among the highest national rates in the world, with an age-standardized incidence near 10 per 100,000 people.² At the city level, the numbers can be even more dramatic: rates among women in Delhi, India have been reported as high as 21.5 per 100,000, and women in South Karachi, Pakistan and Quito, Ecuador also show rates well above global averages.³ High incidence has also been reported in parts of Korea, Japan, and central and eastern Europe.

Women are roughly two to three times more likely to develop gallbladder cancer than men, a gap that likely reflects their higher rates of gallstones along with hormonal influences. Indigenous populations in the Americas, especially those with Amerindian ancestry in Chile and Bolivia, face elevated risk that tracks closely with both high gallstone prevalence and other environmental exposures. Advancing age is a consistent factor everywhere: most diagnoses occur after age 60.⁴

Gallbladder Polyps

Gallbladder polyps are growths that project from the inner wall, and most of them are harmless cholesterol deposits that will never become cancerous. The critical question is size. In a retrospective study of 438 patients with gallbladder polyps, the cancer rate was 0 percent for polyps smaller than 10 mm but jumped to about 6 percent for polyps 10 mm or larger.⁵ A systematic review found that malignant polyps below 6 mm were essentially nonexistent, and flagged polyp size above 6 mm, patient age over 60, the presence of only a single polyp, coexisting gallstones, and Indian ethnicity as features linked to higher cancer risk.⁶

Current guidelines generally recommend removing the gallbladder when a polyp reaches 10 mm or when it is growing on repeat imaging. Smaller polyps are typically monitored with periodic ultrasound. The practical takeaway is that a small polyp found incidentally on an abdominal scan is overwhelmingly likely to be benign, but it does warrant follow-up imaging to confirm it stays small.

Porcelain Gallbladder

A porcelain gallbladder refers to calcium deposits in the gallbladder wall, visible on imaging as a white, shell-like outline. It used to be considered a strong indication for preventive surgery because of assumed high cancer rates. The reality is more nuanced. A study that distinguished between two patterns of calcification found that selective mucosal calcification, where calcium deposits only in the inner lining, carried an odds ratio of about 14 for gallbladder cancer. In contrast, complete intramural calcification, where the entire wall is uniformly calcified, had no cancer cases at all.⁷ The type of calcification, rather than calcification in general, determines the actual risk. Cholecystectomy is still recommended for the mucosal pattern, and many surgeons still remove a porcelain gallbladder of either type as a precaution.⁸

Congenital Biliary Anomalies

Two structural abnormalities present from birth substantially increase gallbladder and bile duct cancer risk. The first is an anomalous pancreaticobiliary duct junction, a condition where the pancreatic duct and bile duct join together outside the wall of the duodenum instead of inside it. This anatomy lets pancreatic juice flow backward into the bile ducts and gallbladder. The refluxed pancreatic enzymes chronically damage the lining, triggering a progression from hyperplasia to dysplasia and eventually cancer through a pathway driven by sustained inflammation rather than the stepwise adenoma-to-carcinoma route seen in many other cancers.⁹ Studies have confirmed that patients with this abnormal junction have a high common channel length, and about 45 percent of bile duct cancer patients in one series had this anatomy.¹⁰

The second is choledochal cysts, which are abnormal dilations of the bile ducts. A meta-analysis of nearly 3,000 patients with choledochal malformations found that about 11 percent developed a malignancy. Types I and IV cysts carried the highest cancer rates, and patients who had been treated with simple drainage rather than complete cyst excision faced roughly fourfold greater odds of developing cancer afterward.¹¹ Complete surgical excision of the cyst is now the standard recommendation, even in children diagnosed incidentally, because the cancer risk persists over a lifetime if the abnormal tissue remains.

Chronic Typhoid Carriage

One of the more unexpected risk factors is long-term carriage of Salmonella typhi, the bacterium that causes typhoid fever. Not an acute bout of typhoid, which does not appear to raise cancer risk, but chronic carriage, where the organism persists in the gallbladder for years after the initial infection clears. A landmark study found that chronic typhoid and paratyphoid carriers had a 167-fold excess of gallbladder cancer compared with the general population, alongside smaller elevations in pancreatic and colorectal cancer. No similar excess appeared among people who had survived an acute typhoid outbreak without becoming carriers.¹²

A meta-analysis pooling multiple studies estimated the overall odds ratio for gallbladder cancer among chronic Salmonella typhi carriers at about 4.3 times that of non-carriers. The association held regardless of whether carrier status was determined by antibody levels or by culturing the organism, and was strongest among controls who did not have gallstones, suggesting that infection acts as an independent risk pathway.¹³ Most of the evidence comes from South and East Asia, where typhoid is endemic. In those regions, antibiotic eradication of chronic carriage may carry cancer-prevention value beyond its infectious disease rationale.

Helicobacter pylori has also been proposed as a gallbladder carcinogen, though the evidence is less consistent. One metagenomics study of bile from gallbladder cancer patients in Bolivia and Chile did not detect Salmonella or Helicobacter at all but found Fusobacterium nucleatum and Enterobacter species as the predominant bacteria.¹⁴ The microbial story is clearly more complex than any single pathogen, and research into the gallbladder microbiome is still in early stages.

Obesity, Diabetes, and Metabolic Risk

Excess body weight consistently raises gallbladder cancer risk. Meta-analyses have found that obesity roughly doubles the risk compared with normal weight for women and increases it by about a third to a half for men.¹⁵ A separate pooled analysis of 14 cohort studies found a broadly consistent pattern, with obese women facing about 78 percent higher risk and obese men about 50 percent higher risk.¹⁶ Part of this likely works through gallstones, since obesity promotes gallstone formation. But obesity also changes bile acid composition, boosts circulating insulin and inflammatory markers, and shifts the hormonal environment in ways that may independently promote cancer.

Type 2 diabetes carries its own independent risk. A meta-analysis of 20 observational studies found that people with diabetes had about 56 percent higher odds of gallbladder cancer compared with non-diabetic individuals, and this relationship held after accounting for smoking, body mass, and gallstone history.¹⁷ A population-based study in Shanghai found that insulin resistance itself, measured by how hard the pancreas works to control blood sugar, was associated with gallbladder cancer risk, with the least insulin-resistant participants having about 60 percent lower odds of the disease.¹⁸

Hormonal and Reproductive Factors

The strong female predominance in gallbladder cancer has prompted research into reproductive and hormonal influences. The evidence is real but surprisingly mixed. A large pooled analysis of Asian cohorts found that women who began menstruating at age 17 or later had about 39 percent higher gallbladder cancer risk compared to those who started at 13 or 14.¹⁹ A Shanghai population study found that having three or more children roughly doubled the risk compared with having one child, and late menarche was again linked to higher risk.²⁰

What stands out, though, is the list of factors that did not show clear associations: breastfeeding, age at menopause, oral contraceptive use, and hormone replacement therapy all failed to reach significance in the larger pooled analysis.¹⁹ The hormonal picture, then, is not a simple story of estrogen exposure driving cancer the way it does in breast tissue. The connection may run partly through gallstone formation, which pregnancy and hormonal shifts promote, rather than through direct hormonal effects on gallbladder cells.

Environmental Exposures and Dietary Contaminants

In regions with the highest gallbladder cancer rates, environmental contamination adds another layer of risk. A comparative study between India and Japan found significantly higher levels of chromium, lead, and arsenic in gallbladder cancer tissue from Indian patients compared with Japanese patients.²¹ Heavy metals can accumulate in bile and gallbladder tissue over decades, acting as direct mutagens or amplifying the inflammatory damage already caused by gallstones.

Aflatoxins, toxic compounds produced by molds on grains and other crops, are another suspect. In southern Chile, where gallbladder cancer rates are among the world’s highest, a study estimated that dietary aflatoxin exposure was widespread and found significantly more aflatoxin biomarkers in gallbladder cancer patients than in controls, with an odds ratio of 13.²² Aflatoxins are well established as liver carcinogens, and the hypothesis is that they reach the gallbladder through bile after being processed by the liver. The overlap of high Amerindian ancestry, high gallstone prevalence, poverty, cereal-heavy diets, and aflatoxin contamination in the same populations makes it difficult to tease apart individual contributions, but the biological plausibility is strong.

Bile Acid Changes

The gallbladder concentrates and stores bile, so the chemical composition of that bile matters. Several studies have documented increased levels of secondary bile acids in gallbladder cancer patients. Secondary bile acids are formed when gut bacteria convert the primary bile acids made by the liver. These secondary products are more cytotoxic and can damage DNA. However, the data here remain genuinely uncertain. Some studies found elevated secondary bile acids in cancer patients while others found higher primary bile acids in gallstone patients without cancer. Sample sizes have been small, and it is not yet clear whether bile acid shifts are a cause of cancer, a consequence of it, or simply a marker of the disordered gallbladder environment that produced both the stones and the cancer.²³

Familial Risk and Inherited Susceptibility

Most gallbladder cancer appears sporadic, but there is a small familial component. A Swedish registry study found that about 4 percent of gallbladder cancers occurred in patients who had a first-degree relative with the same diagnosis. The familial relative risk was 2.76, meaning that having a close family member with gallbladder cancer roughly tripled your own odds.²⁴ Sweden is a low-incidence country, so these familial proportions may differ in high-risk populations, but the pattern suggests that shared genetics, shared environment, or both play a role in a minority of cases.

At the tumor level, the genetic landscape of gallbladder cancer is becoming clearer. Genomic profiling of gallbladder tumors has identified TP53 mutations in the vast majority of cases, along with frequent alterations in SMAD4, NOTCH1, ERBB2, and PIK3CA.²⁵ Separately, KRAS mutations have been linked to worse survival.²⁶ The encouraging clinical detail is that roughly 90 percent of gallbladder tumors in one profiling study carried mutations that are theoretically targetable with existing drugs, though targeted therapies for this cancer remain in early trial phases. This molecular work is useful for treatment planning but has not yet translated into the kind of screening or risk-assessment tools that exist for better-studied cancers like breast or colon.

Why So Many Risk Factors Overlap

One reason the cause of gallbladder cancer can seem confusing is that virtually all of the risk factors feed into each other. Obesity promotes gallstones. Gallstones promote chronic inflammation. Chronic inflammation changes bile composition. Altered bile favors bacterial overgrowth. Bacterial infection worsens inflammation. Pregnancy promotes gallstones and shifts hormones. Poverty increases exposure to contaminated food and chronic infections while decreasing access to cholecystectomy. Indigenous populations in high-risk regions face several of these factors simultaneously, which helps explain why gallbladder cancer clusters so intensely in certain groups.

This web of interacting causes is also why prevention is hard to reduce to a single intervention. Cholecystectomy eliminates the organ and therefore the cancer risk, but performing it on every person with gallstones would be massive overkill given how common stones are and how rare the cancer is. Current clinical recommendations target the highest-risk scenarios: prophylactic removal of a porcelain gallbladder with mucosal calcification, removal of large or growing polyps, excision of choledochal cysts, and cholecystectomy for people with the anomalous pancreaticobiliary duct junction.⁸ For everyone else, managing the modifiable metabolic risks like weight and diabetes control, treating chronic infections, and monitoring polyps with imaging are the practical levers available.

Aflatoxin Exposure and the Poverty Connection

The link between gallbladder cancer and poverty deserves separate attention because it operates through multiple pathways at once. In low-income agricultural communities, grain storage conditions favor mold growth and aflatoxin contamination. Water supplies may carry heavy metals or Salmonella. Diets heavy in starchy staples and low in fresh produce promote obesity and gallstone formation. Access to elective surgery like cholecystectomy for symptomatic gallstones is limited, so stones persist and grow larger for years. And public health infrastructure for typhoid vaccination or carrier detection may be thin. The result is that populations exposed to the most risk factors are also the least likely to have them detected or treated early. In southern Chile, the convergence of Amerindian genetic susceptibility, aflatoxin-contaminated diets, and limited surgical access has created gallbladder cancer rates that are more than ten times the global average.²² Understanding gallbladder cancer as partly a disease of poverty reframes prevention away from individual clinical decisions and toward sanitation, food safety, and access to routine surgical care.